Last Updated: June 23, 2026

Investigational Drug Information for HEC96719


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug HEC96719?

HEC96719 is an investigational drug.

There have been 4 clinical trials for HEC96719. The most recent clinical trial was a Phase 1 trial, which was initiated on November 15th 2021.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Sunshine Lake Pharma Co., Ltd. and [disabled in preview].

There are three US patents protecting this investigational drug.

Recent Clinical Trials for HEC96719
TitleSponsorPhase
A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic SteatohepatitisSunshine Lake Pharma Co., Ltd.Phase 2
Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult SubjectsSunshine Lake Pharma Co., Ltd.Phase 1
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy SubjectsSunshine Lake Pharma Co., Ltd.Phase 1

See all HEC96719 clinical trials

Clinical Trial Summary for HEC96719

Top disease conditions for HEC96719
Top clinical trial sponsors for HEC96719

See all HEC96719 clinical trials

US Patents for HEC96719

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
HEC96719 ⤷  Start Trial Nitrogen-containing tricyclic compounds and uses thereof in medicine Sunshine Lake Pharma Co Ltd ⤷  Start Trial
HEC96719 ⤷  Start Trial Nitrogenous tricyclic compounds and uses thereof in medicine Sunshine Lake Pharma Co Ltd ⤷  Start Trial
HEC96719 ⤷  Start Trial Crystalline form of nitrogen-containing tricyclic compound and use thereof Sunshine Lake Pharma Co Ltd ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.